Autopsy report · NCT01520168

Composix Kugel Mesh Recall Leaves Unresolved Problems of Patient Management

“Because of the product recall 2005/2006.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 years 3 months after it had already started.
• Suspended: paused, and may or may not restart.
• 21 participants enrolled.

Vital statistics

Status

Suspended

Sponsor

University of Wuerzburg

Sponsor type

University, hospital or other

Conditions

Incisional Hernia

Participants

21

Sites

1

Countries

Germany

Trials that died the same way

• Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
  “Due to business reasons” (64% match in meaning)
• Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
  “Due to financial reasons.” (61% match in meaning)
• Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
  “Due to a lack of safety and efficacy.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.